- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01799239
Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura
Investigating the Safety and Performance of Newly Developed 1-piece Ostomy Product Concept Compared With SenSura 1-piece in Subjects With an Ileostomy
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Skövde, Sweden, 541 85
- Skövde Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Be able to handle the bags themselves
- Have an ileostomy with a diameter between 15 and 55 mm
- Have had their ileostomy for at least 3 months
- Currently use a 1-piece flat ostomy appliance with open bag
- Use minimum 1 product every second day, i.e. maximum 2 days wear time
- Be suitable for participation in the study and for using a standard adhesive, flat base plate
- Must be able and willing to use custom cut products
- Accept to test two 1-piece products within the study period
Exclusion Criteria:
- Use irrigation during the study period (flush the intestines with water)
- Currently receiving or have within the past 2 months received chemotherapy or radiation therapy
- Currently receiving or have within the past month received systematic steroid or local treatment in the peristomal area
- Are pregnant or breastfeeding
- Participating in other interventional clinical investigations or have previously participated in this investigation
- Currently using a ostomy belt
- Currently using extended wear product
- Have a loop ileostomy
- Known hypersensitivity towards any of the test products
- Suffering from severe peristomal skin problems prior to participation in the investigation (assessed by the study nurse)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: First Test product; then SenSura
The subject in this arm first test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details. After cross-over the subject test SenSura which is CE-marked and commerical available. |
The test product consists of an adhesive with a new top film
SenSura is the CE-marked and commercially available comparator product
|
|
Active Comparator: First SenSura, Then Test product
The subject in this arm first test SenSura which is CE-marked and commerical available. After cross-over the subject test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details. |
The test product consists of an adhesive with a new top film
SenSura is the CE-marked and commercially available comparator product
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leakage (Percentage of All Baseplates With Leakage)
Time Frame: After each baseplate change over a period, of 7 days
|
leakage is measured using a 4-point leakage scale developed by Coloplast A/S. At every baseplate change the subjects had to look at the skin facing side of the baseplate and access which of the four scenarios described below provided an accurate description of the baseplate. The subjects tick of one of the four possible answers:
|
After each baseplate change over a period, of 7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CP237
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ileostomy - Stoma
-
WiGeV Klinik OttakringRecruitingIleostomy - Stoma | Absorption | Stoma Ileostomy | Pharmakokinetic | Colostomy - StomaAustria
-
University of California, San DiegoRecruitingIleostomy; Complications | Stoma IleostomyUnited States
-
11 Heath and Technologies LimitedThe Cleveland ClinicUnknownIleostomy; Complications | Ileostomy - StomaUnited States
-
Chang Gung Memorial HospitalConvaTect, TaiwanUnknownStoma Ileostomy | Stoma ColostomyTaiwan
-
Coloplast A/SCompleted
-
Hospital de BasurtoAlberto Loizate Totoricaguena; Pedro García AlonsoUnknownIleostomy; Complications | Ileostomy - Stoma | Stoma Ileostomy | Ileus ParalyticSpain
-
BBraun Medical SASRecruitingEnterostomy | Stoma Ileostomy | Stoma ColostomySpain
-
Massachusetts General HospitalCompletedSurgery | Ileostomy - Stoma | Colostomy StomaUnited States
-
NorthShore University HealthSystemCompletedIleostomy; Complications | Ileostomy - StomaUnited States
-
Asian Institute of Gastroenterology, IndiaNot yet recruiting
Clinical Trials on Test product
-
Boehringer IngelheimCompleted
-
Danone ResearchCompleted
-
IBSA Farmaceutici Italia SrlInformapro SrlRecruitingSupplementation | Hypercholesterolemia and HyperlipidemiaItaly
-
Coloplast A/SCompletedCompliance, PatientDenmark
-
Coloplast A/SCompletedStoma Site LeakageDenmark
-
GlaxoSmithKlineCompletedDenture RetentionUnited States
-
Liquid I.V.University of MemphisCompleted
-
Medicis Global Service CorporationCompletedSeborrheic DermatitisUnited States
-
Pierre Fabre Dermo CosmetiqueRecruiting